- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Evaluation of Efficacy of Oral Acyclovir in Herpes Zoster. Trial of 2400mg 3 times daily.
-
- Sugiyama Yuri
- Department of Dermatology, Kinki University School of Medicine
-
- Tamura Takahiro
- Department of Dermatology, Kinki University School of Medicine
-
- Seguchi Tokuji
- Department of Dermatology, Kinki University School of Medicine
-
- Yoshida Masami
- Department of Dermatology, Kinki University School of Medicine
-
- Tezuka Tadashi
- Department of Dermatology, Kinki University School of Medicine
Bibliographic Information
- Other Title
-
- アシクロビル(400mg)錠内服による帯状ほう疹の治療効果
- 1日3回, 1回2錠 (800mg) 投与の試み
Search this article
Description
We evaluated the therapeutic effects of oral acyclovir (2400mg) administered 3 times daily to 20 patients with mild, moderate and severe attacks of herpes zoster. The final global improvement rate was 100% (13/13) for mild attacks and 85.7% (6/7) for moderate and severe attacks. The rate of marked improvement was 38.5% (5/13) for mild attacks. Although the standard dosage was reported to be 4000mg 5 times daily, our results suggest that 2400mg of oral acyclovir 3 times daily is also effective in mild cases of herpes zoster.
Journal
-
- Skin research
-
Skin research 36 (3), 459-464, 1994
Meeting of Osaka Dermatological Association
- Tweet
Details 詳細情報について
-
- CRID
- 1390282679776038528
-
- NII Article ID
- 130003843921
-
- ISSN
- 1884541X
- 00181390
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- CiNii Articles
-
- Abstract License Flag
- Disallowed